CPHA Canvax
CPHA Canvax

Variants, the J&J Vaccine, VIIT, and more

AUDIOVISUAL

"We continue our discussion about COVID-19 with a deeper dive into the Variants of Concern, the Johnson & Johnson vaccine, and how to help your patients weigh the risks and benefits of the viral vector vaccines in light of Vaccine Induced Immune Thrombotic Thrombocytopenia (VIIT)." - Variants, the J&J Vaccine, VIIT, and more


Web link

Variants, the J&J Vaccine, VIIT, and more

Related Resources

Bookmark

Implementation Tool

Audiovisual
Author: Menaka Pai, Allison McGeer, David Kaplan, Liz Muggah Published: 2021 Region: National Audience: Health Care Professional Product Type: Webinar Language: English Population: Adults Organization: Family and Community Medicine University of Toronto, Ontario Family Physicians

Category

Vaccine Safety and Development,Research and Development,Vaccine Development,Vaccine Safety,Vaccine Safety,Adverse Events Following Immunization (AEFI),Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Research and Development
Vaccine Development
Vaccine Safety
Vaccine Safety
Adverse Events Following Immunization (AEFI)
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.

Login or register to comment